{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:31:26Z","timestamp":1792791086791,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1112389"],"award-info":[{"award-number":["OPP1112389"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HMcS holds a Wellcome Trust Investigator award","award":["WT 206331\/Z\/17\/Z"],"award-info":[{"award-number":["WT 206331\/Z\/17\/Z"]}],"id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bacille Calmette-Gu\u00e9rin (BCG), the only currently licenced tuberculosis vaccine, may exert beneficial non-specific effects (NSE) in reducing infant mortality. We conducted a randomised controlled clinical study in healthy UK adults to evaluate potential NSE using functional in-vitro growth inhibition assays (GIAs) as a surrogate of protection from four bacteria implicated in infant mortality. Volunteers were randomised to receive BCG intradermally (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200927) or to be unvaccinated (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098) and were followed up for 84\u00a0days; laboratory staff were blinded until completion of the final visit. Using GIAs based on peripheral blood mononuclear cells, we observed a significant reduction in the growth of the Gram-negative bacteria\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    and\n                    <jats:italic>Klebsiella pneumonia<\/jats:italic>\n                    following BCG vaccination, but no effect for the Gram-positive bacteria\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    and\n                    <jats:italic>Streptococcus agalactiae<\/jats:italic>\n                    . There was a modest association between\n                    <jats:italic>S. aureus<\/jats:italic>\n                    nasal carriage and growth of\n                    <jats:italic>S. aureus<\/jats:italic>\n                    in the GIA. Our findings support a causal link between BCG vaccination and improved ability to control growth of heterologous bacteria. Unbiased assays such as GIAs are potentially useful tools for the assessment of non-specific as well as specific effects of TB vaccines. This study was funded by the Bill and Melinda Gates Foundation and registered with ClinicalTrials.gov (NCT02380508, 05\/03\/2015; completed).\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-11748-x","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T05:03:46Z","timestamp":1652331826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study"],"prefix":"10.1038","volume":"12","author":[{"given":"Morven","family":"Wilkie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Lopez Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Beglov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Riste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo J. G.","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline M.","family":"van Diemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Satti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"11748_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","volume":"22","author":"LC Rodrigues","year":"1993","unstructured":"Rodrigues, L. C., Diwan, V. K. & Wheeler, J. G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int. J. Epidemiol. 22, 1154\u20131158 (1993).","journal-title":"Int. J. Epidemiol."},{"key":"11748_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","volume":"346","author":"PE Fine","year":"1995","unstructured":"Fine, P. E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339\u20131345 (1995).","journal-title":"Lancet"},{"key":"11748_CR3","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.3389\/fimmu.2018.02869","volume":"9","author":"D Uthayakumar","year":"2018","unstructured":"Uthayakumar, D. et al. Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations. Front. Immunol. 9, 2869 (2018).","journal-title":"Front. Immunol."},{"key":"11748_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/01.inf.0000129693.81082.a0","volume":"23","author":"A Roth","year":"2004","unstructured":"Roth, A. et al. Low birth weight infants and Calmette-Gu\u00e9rin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatr. Infect. Dis. J. 23, 544\u2013550 (2004).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"11748_CR5","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1016\/j.vaccine.2012.09.035","volume":"30","author":"S Hirve","year":"2012","unstructured":"Hirve, S. et al. Non-specific and sex-differential effects of vaccinations on child survival in rural western India. Vaccine 30, 7300\u20137308. https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.035 (2012).","journal-title":"Vaccine"},{"key":"11748_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/ije\/dyh392","volume":"34","author":"A Roth","year":"2005","unstructured":"Roth, A. et al. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int. J. Epidemiol. 34, 540\u2013547 (2005).","journal-title":"Int. J. Epidemiol."},{"key":"11748_CR7","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","volume":"21","author":"ML Garly","year":"2003","unstructured":"Garly, M. L. et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?. Vaccine 21, 2782\u20132790 (2003).","journal-title":"Vaccine"},{"key":"11748_CR8","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","volume":"321","author":"I Kristensen","year":"2000","unstructured":"Kristensen, I., Aaby, P. & Jensen, H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 321, 1435\u20131438 (2000).","journal-title":"BMJ"},{"key":"11748_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby, P. et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. J. Infect. Dis. 204, 245\u2013252. https:\/\/doi.org\/10.1093\/infdis\/jir240 (2011).","journal-title":"J. Infect. Dis."},{"key":"11748_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12889-015-1497-8","volume":"15","author":"V Nankabirwa","year":"2015","unstructured":"Nankabirwa, V., Tumwine, J. K., Mugaba, P. M., Tyllesk\u00e4r, T. & Sommerfelt, H. Child survival and BCG vaccination: a community based prospective cohort study in Uganda. BMC Public Health 15, 175. https:\/\/doi.org\/10.1186\/s12889-015-1497-8 (2015).","journal-title":"BMC Public Health"},{"key":"11748_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(20)30653-8","author":"S Prentice","year":"2021","unstructured":"Prentice, S. et al. BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/s1473-3099(20)30653-8 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"11748_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes, E. et al. Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination. N. Engl. J. Med. 379, 138\u2013149. https:\/\/doi.org\/10.1056\/NEJMoa1714021 (2018).","journal-title":"N. Engl. J. Med."},{"key":"11748_CR13","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","volume":"23","author":"LG Stensballe","year":"2005","unstructured":"Stensballe, L. G. et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls: community based case\u2013control study. Vaccine 23, 1251\u20131257. https:\/\/doi.org\/10.1016\/j.vaccine.2004.09.006 (2005).","journal-title":"Vaccine"},{"key":"11748_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/01.ede.0000231546.14749.ab","volume":"17","author":"A Roth","year":"2006","unstructured":"Roth, A. et al. Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology 17, 562\u2013568. https:\/\/doi.org\/10.1097\/01.ede.0000231546.14749.ab (2006).","journal-title":"Epidemiology"},{"key":"11748_CR15","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1016\/j.vaccine.2006.03.038","volume":"24","author":"P Aaby","year":"2006","unstructured":"Aaby, P., Jensen, H. & Walraven, G. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia. Vaccine 24, 4701\u20134708. https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.038 (2006).","journal-title":"Vaccine"},{"key":"11748_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/01.inf.0000227829.64686.ae","volume":"25","author":"P Aaby","year":"2006","unstructured":"Aaby, P. et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr. Infect. Dis. J. 25, 721\u2013727. https:\/\/doi.org\/10.1097\/01.inf.0000227829.64686.ae (2006).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"11748_CR17","unstructured":"Higgins, J. P. T., Soares-Weiser, K. & Reingold, A. (2014)."},{"key":"11748_CR18","doi-asserted-by":"publisher","first-page":"i5170","DOI":"10.1136\/bmj.i5170","volume":"355","author":"JPT Higgins","year":"2016","unstructured":"Higgins, J. P. T. et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 355, i5170 (2016).","journal-title":"BMJ"},{"key":"11748_CR19","doi-asserted-by":"publisher","first-page":"632478","DOI":"10.3389\/fimmu.2021.632478","volume":"12","author":"M Gonzalez-Perez","year":"2021","unstructured":"Gonzalez-Perez, M., Sanchez-Tarjuelo, R., Shor, B., Nistal-Villan, E. & Ochando, J. The BCG vaccine for COVID-19: first verdict and future directions. Front. Immunol. 12, 632478\u2013632478. https:\/\/doi.org\/10.3389\/fimmu.2021.632478 (2021).","journal-title":"Front. Immunol."},{"key":"11748_CR20","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1128\/JVI.02393-08","volume":"83","author":"KS Mathurin","year":"2009","unstructured":"Mathurin, K. S., Martens, G. W., Kornfeld, H. & Welsh, R. M. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J. Virol. 83, 3528\u20133539 (2009).","journal-title":"J. Virol."},{"key":"11748_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis, J. et al. Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J. Innate Immun. 6, 152\u2013158 (2014).","journal-title":"J. Innate Immun."},{"key":"11748_CR22","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis, J. et al. Bacille calmette-guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl. Acad. Sci. USA 109, 17537\u201317542. https:\/\/doi.org\/10.1073\/pnas.1202870109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11748_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","volume":"155","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis, J. et al. BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin. Immunol. 155, 213\u2013219. https:\/\/doi.org\/10.1016\/j.clim.2014.10.005 (2014).","journal-title":"Clin. Immunol."},{"key":"11748_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.4049\/jimmunol.166.2.1097","volume":"166","author":"G Lertmemongkolchai","year":"2001","unstructured":"Lertmemongkolchai, G., Cai, G., Hunter, C. A. & Bancroft, G. J. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-\u03b3 in response to bacterial pathogens. J. Immunol. 166, 1097\u20131105 (2001).","journal-title":"J. Immunol."},{"key":"11748_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science https:\/\/doi.org\/10.1126\/science.aaf1098 (2016).","journal-title":"Science"},{"key":"11748_CR26","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/ije\/dyw244","volume":"45","author":"S Haahr","year":"2016","unstructured":"Haahr, S. et al. Non-specific effects of BCG vaccination on morbidity among children in Greenland: a population-based cohort study. Int. J. Epidemiol. 45, 2122\u20132130. https:\/\/doi.org\/10.1093\/ije\/dyw244 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"11748_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-310760","author":"LG Stensballe","year":"2016","unstructured":"Stensballe, L. G. et al. BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial. Arch. Dis. Childhood. https:\/\/doi.org\/10.1136\/archdischild-2016-310760 (2016).","journal-title":"Arch. Dis. Childhood."},{"key":"11748_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/inf.0000000000002198","volume":"38","author":"K Jayaraman","year":"2019","unstructured":"Jayaraman, K. et al. Two randomized trials of the effect of the Russian strain of Bacillus Calmette-Guerin alone or with oral polio vaccine on neonatal mortality in infants weighing <2000 g in India. Pediatr. Infect. Dis. J. 38, 198\u2013202. https:\/\/doi.org\/10.1097\/inf.0000000000002198 (2019).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"11748_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1365-3156.2009.02302.x","volume":"14","author":"CP Farrington","year":"2009","unstructured":"Farrington, C. P. et al. Epidemiological studies of the non-specific effects of vaccines: II\u2014methodological issues in the design and analysis of cohort studies. Trop. Med. Int. Health TM IH 14, 977\u2013985 (2009).","journal-title":"Trop. Med. Int. Health TM IH"},{"key":"11748_CR30","unstructured":"World Health, O. Meeting of the strategic advisory group of experts on immunization, April 2014\u2014conclusions and recommendations. Weekly Epidemiol. Rec. Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire 89, 221-236 (2014)."},{"key":"11748_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","volume":"7","author":"VN Raabe","year":"2019","unstructured":"Raabe, V. N. & Shane, A. L. Group B streptococcus (Streptococcus agalactiae). Microbiol. Spect. 7, 7 (2019).","journal-title":"Microbiol. Spect."},{"key":"11748_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3201\/eid2504.180935","volume":"25","author":"A Odutola","year":"2019","unstructured":"Odutola, A. et al. Staphylococcus aureus bacteremia in children of rural areas of The Gambia, 2008\u20132015. Emerg. Infect. Dis. 25, 701 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"11748_CR33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","volume":"18","author":"IA Khalil","year":"2018","unstructured":"Khalil, I. A. et al. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the global burden of disease study 1990\u20132016. Lancet Infect. Dis. 18, 1229\u20131240 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"11748_CR34","first-page":"3","volume":"32","author":"D Marangu","year":"2019","unstructured":"Marangu, D. & Zar, H. J. Childhood pneumonia in low-and-middle-income countries: an update. Paediat. Resp. Rev. 32, 3\u20139 (2019).","journal-title":"Paediat. Resp. Rev."},{"key":"11748_CR35","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1086\/599119","volume":"199","author":"A van Belkum","year":"2009","unstructured":"van Belkum, A. et al. Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 199, 1820\u20131826. https:\/\/doi.org\/10.1086\/599119 (2009).","journal-title":"J. Infect. Dis."},{"key":"11748_CR36","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1128\/CVI.00427-13","volume":"20","author":"HA Fletcher","year":"2013","unstructured":"Fletcher, H. A. et al. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin. Vaccine Immunol. 20, 1683\u20131689. https:\/\/doi.org\/10.1128\/CVI.00427-13 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"11748_CR37","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/nm1128","volume":"10","author":"H McShane","year":"2004","unstructured":"McShane, H. et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10, 1240\u20131244. https:\/\/doi.org\/10.1038\/nm1128 (2004).","journal-title":"Nat. Med."},{"key":"11748_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.01.006","author":"R Tanner","year":"2019","unstructured":"Tanner, R. et al. Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells. J. Immunol. Methods https:\/\/doi.org\/10.1016\/j.jim.2019.01.006 (2019).","journal-title":"J. Immunol. Methods"},{"key":"11748_CR39","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3389\/fimmu.2019.02983","volume":"10","author":"R Tanner","year":"2020","unstructured":"Tanner, R. et al. Tools for assessing the protective efficacy of TB vaccines in humans: in vitro Mycobacterial growth inhibition predicts outcome of in vivo Mycobacterial infection. Front. Immunol. 10, 2983 (2020).","journal-title":"Front. Immunol."},{"key":"11748_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2019.01.006","volume":"469","author":"R Tanner","year":"2019","unstructured":"Tanner, R. et al. Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells. J. Immunol. Methods 469, 1\u201310. https:\/\/doi.org\/10.1016\/j.jim.2019.01.006 (2019).","journal-title":"J. Immunol. Methods"},{"key":"11748_CR41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/cvi.00349-16","volume":"23","author":"S Bekkering","year":"2016","unstructured":"Bekkering, S. et al. In vitro experimental model of trained innate immunity in human primary monocytes. Clin. Vaccine Immunol. 23, 926\u2013933. https:\/\/doi.org\/10.1128\/cvi.00349-16 (2016).","journal-title":"Clin. Vaccine Immunol."},{"key":"11748_CR42","doi-asserted-by":"publisher","first-page":"43478","DOI":"10.1038\/srep43478","volume":"7","author":"R Tanner","year":"2017","unstructured":"Tanner, R. et al. The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays. Sci. Rep. 7, 43478. https:\/\/doi.org\/10.1038\/srep43478 (2017).","journal-title":"Sci. Rep."},{"key":"11748_CR43","doi-asserted-by":"publisher","first-page":"108387","DOI":"10.1016\/j.celrep.2020.108387","volume":"33","author":"S Moorlag","year":"2020","unstructured":"Moorlag, S. et al. BCG vaccination induces long-term functional reprogramming of human neutrophils. Cell Rep. 33, 108387 (2020).","journal-title":"Cell Rep."},{"key":"11748_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1084\/jem.119.1.53","volume":"119","author":"DW Weiss","year":"1964","unstructured":"Weiss, D. W., Bonhag, R. S. & Parks, J. A. Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG): I. Antimicrobial protection. J. Exp. Med. 119, 53\u201370. https:\/\/doi.org\/10.1084\/jem.119.1.53 (1964).","journal-title":"J. Exp. Med."},{"key":"11748_CR45","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/infdis\/jiy069","volume":"217","author":"B Freyne","year":"2018","unstructured":"Freyne, B. et al. Neonatal BCG vaccination influences cytokine responses to toll-like receptor ligands and heterologous antigens. J. Infect. Dis. 217, 1798\u20131808 (2018).","journal-title":"J. Infect. Dis."},{"key":"11748_CR46","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/sj.bjp.0706815","volume":"148","author":"MJ Paul-Clark","year":"2006","unstructured":"Paul-Clark, M. J. et al. Differential effects of gram-positive versus gram-negative bacteria on NOSII and TNFalpha in macrophages: role of TLRs in synergy between the two. Br. J. Pharmacol. 148, 1067\u20131075. https:\/\/doi.org\/10.1038\/sj.bjp.0706815 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"11748_CR47","doi-asserted-by":"publisher","first-page":"21288","DOI":"10.1038\/srep21288","volume":"6","author":"J Sn\u00e4ll","year":"2016","unstructured":"Sn\u00e4ll, J. et al. Differential neutrophil responses to bacterial stimuli: Streptococcal strains are potent inducers of heparin-binding protein and resistin-release. Sci. Rep. 6, 21288. https:\/\/doi.org\/10.1038\/srep21288 (2016).","journal-title":"Sci. Rep."},{"key":"11748_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/01.inf.0000129693.81082.a0","volume":"23","author":"A Roth","year":"2004","unstructured":"Roth, A. et al. Low birth weight infants and calmette-gu\u00e9rin bacillus vaccination at birth: community study from guinea-bissau. Pediat. Infect. Dis. J. 23, 544\u2013550 (2004).","journal-title":"Pediat. Infect. Dis. J."},{"key":"11748_CR49","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","volume":"359","author":"GF Black","year":"2002","unstructured":"Black, G. F. et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359, 1393\u20131401. https:\/\/doi.org\/10.1016\/S0140-6736(02)08353-8 (2002).","journal-title":"Lancet"},{"key":"11748_CR50","first-page":"231","volume":"1","author":"AI Mosa","year":"2021","unstructured":"Mosa, A. I. Rescuing immunosenescence via non-specific vaccination. Immunology 1, 231\u2013239 (2021).","journal-title":"Immunology"},{"key":"11748_CR51","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3389\/fmicb.2018.02419","volume":"9","author":"A Sakr","year":"2018","unstructured":"Sakr, A., Br\u00e9geon, F., M\u00e8ge, J.-L., Rolain, J.-M. & Blin, O. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Front. Microbiol. 9, 2419\u20132419. https:\/\/doi.org\/10.3389\/fmicb.2018.02419 (2018).","journal-title":"Front. Microbiol."},{"key":"11748_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1473-3099(13)70036-7","volume":"13","author":"CDJ den Heijer","year":"2013","unstructured":"den Heijer, C. D. J. et al. Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S. aureus, in nine European countries: a cross-sectional study. Lancet Infect. Dis. 13, 409\u2013415. https:\/\/doi.org\/10.1016\/S1473-3099(13)70036-7 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"11748_CR53","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1086\/423376","volume":"39","author":"JL Nouwen","year":"2004","unstructured":"Nouwen, J. L. et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a \u201cculture rule\u201d. Clin. Infect. Dis. 39, 806\u2013811. https:\/\/doi.org\/10.1086\/423376 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"11748_CR54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S1473-3099(16)30512-6","volume":"17","author":"O Denis","year":"2017","unstructured":"Denis, O. Route of transmission of Staphylococcus aureus. Lancet Infect. Dis. 17, 124\u2013125. https:\/\/doi.org\/10.1016\/S1473-3099(16)30512-6 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"11748_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00281-011-0295-3","volume":"34","author":"KM Rigby","year":"2012","unstructured":"Rigby, K. M. & DeLeo, F. R. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 34, 237\u2013259. https:\/\/doi.org\/10.1007\/s00281-011-0295-3 (2012).","journal-title":"Semin. Immunopathol."},{"key":"11748_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/nejm200101043440102","volume":"344","author":"C von Eiff","year":"2001","unstructured":"von Eiff, C., Becker, K., Machka, K., Stammer, H. & Peters, G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N. Engl. J. Med. 344, 11\u201316. https:\/\/doi.org\/10.1056\/nejm200101043440102 (2001).","journal-title":"N. Engl. J. Med."},{"issue":"998","key":"11748_CR57","doi-asserted-by":"publisher","first-page":"e991","DOI":"10.1016\/j.cmi.2015.07.006","volume":"21","author":"H Ghasemzadeh-Moghaddam","year":"2015","unstructured":"Ghasemzadeh-Moghaddam, H. et al. Nasal carriers are more likely to acquire exogenous <em>Staphylococcus aureus<\/em> strains than non-carriers. Clin. Microbiol. Infect. 21(998), e991-998.e997. https:\/\/doi.org\/10.1016\/j.cmi.2015.07.006 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"11748_CR58","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1128\/cdli.8.6.1064-1069.2001","volume":"8","author":"AM Cole","year":"2001","unstructured":"Cole, A. M. et al. Determinants of Staphylococcus aureus nasal carriage. Clin. Diagn. Lab. Immunol. 8, 1064\u20131069. https:\/\/doi.org\/10.1128\/cdli.8.6.1064-1069.2001 (2001).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"11748_CR59","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/iai.00078-10","volume":"78","author":"P Zanger","year":"2010","unstructured":"Zanger, P. et al. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2. Infect. Immun. 78, 3112\u20133117. https:\/\/doi.org\/10.1128\/iai.00078-10 (2010).","journal-title":"Infect. Immun."},{"key":"11748_CR60","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1128\/iai.71.7.3730-3739.2003","volume":"71","author":"K Midorikawa","year":"2003","unstructured":"Midorikawa, K. et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 71, 3730\u20133739. https:\/\/doi.org\/10.1128\/iai.71.7.3730-3739.2003 (2003).","journal-title":"Infect. Immun."},{"key":"11748_CR61","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1556\/1886.2017.00028","volume":"7","author":"H Frickmann","year":"2017","unstructured":"Frickmann, H. et al. Influence of broth enrichment as well as storage and transport time on the sensitivity of MRSA surveillance in the tropics. Eur. J. Microbiol. Immunol. 7, 274\u2013277. https:\/\/doi.org\/10.1556\/1886.2017.00028 (2017).","journal-title":"Eur. J. Microbiol. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11748-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11748-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11748-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:33:05Z","timestamp":1669325585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11748-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11748"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11748-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7808"}}